Worthington John Mark, Goumas Chris, Jalaludin Bin, Gattellari Melina
Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
South Western Sydney Clinical School UNSW, Liverpool, NSW, Australia.
Front Neurol. 2017 Aug 31;8:424. doi: 10.3389/fneur.2017.00424. eCollection 2017.
Subarachnoid hemorrhage (SAH) is associated with a high risk of mortality and disability in survivors. We examined the epidemiology and burden of SAH in our population during a time services were re-organized to facilitate access to evidence-based endovascular coiling and neurosurgical care.
SAH hospitalizations from 2001 to 2009, in New South Wales, Australia, were linked to death registrations to June 30, 2010. We assessed the variability of admission rates, fatal SAH rates and case fatality over time and according to patient demographic characteristics.
There were 4,945 eligible patients admitted to hospital with SAH. The risk of fatal SAH significantly decreased by 2.7% on average per year (95% CI = 0.3-4.9%). Case fatality at 2, 30, 90, and 365 days significantly declined over time. The average annual percentage reduction in mortality ranged from 4.4% for 30-day mortality (95% CI -6.1 to -2.7) ( < 0.001) to 4.7% for mortality within 2 days (-7.1 to -2.2) ( < 0.001) (Table 3). Three percent of patients received coiling at the start of the study period, increasing to 28% at the end (-value for trend <0.001). Females were significantly more likely to be hospitalized for a SAH compared to males [incident rate ratio (IRR) = 1.33, 95% CI = 1.23-1.44] ( < 0.001) and to die from SAH (IRR = 1.40, 95% CI = 1.24-1.59) ( < 0.001). People born in South-East Asia and the Oceania region had a significantly increased risk of SAH, while the risk of fatal SAH was greater in South-East and North-East Asian born residents. People residing in areas of least disadvantage had the lowest risk of hospitalization (IRR = 0.83, 95% CI = 0.74-0.92) and also the lowest risk of fatal SAH (0.81, 95% CI = 0.66-1.00) ( < 0.001 and = 0.003, respectively). For every 100 SAH admissions, 20 and 15 might be avoided in males and females, respectively, if the risk of SAH in our population equated to that of the most socio-economically advantaged.
Our study reports reductions in mortality risk in SAH corresponding to identifiable changes in health service delivery and evolving treatments such as coiling. Addressing inequities in SAH risk and mortality may require the targeting of prevalent and modifiable risk factors to improve population outcomes.
蛛网膜下腔出血(SAH)幸存者的死亡和残疾风险很高。我们在重新组织服务以促进循证血管内栓塞和神经外科护理的时期,研究了我们人群中SAH的流行病学和负担。
将澳大利亚新南威尔士州2001年至2009年的SAH住院病例与截至2010年6月30日的死亡登记相联系。我们评估了入院率、致命性SAH率和病死率随时间以及根据患者人口统计学特征的变化情况。
有4945例符合条件的患者因SAH入院。致命性SAH的风险平均每年显著降低2.7%(95%置信区间=0.3 - 4.9%)。2天、30天、90天和365天的病死率随时间显著下降。死亡率的年均百分比下降幅度从30天死亡率的4.4%(95%置信区间-6.1至-2.7)(<0.001)到2天内死亡率的4.7%(-7.1至-2.2)(<0.001)(表3)。在研究期开始时,3%的患者接受了栓塞治疗,到结束时增至28%(趋势P值<0.001)。与男性相比,女性因SAH住院的可能性显著更高[发病率比(IRR)=1.33,95%置信区间=1.23 - 1.44](<0.001),死于SAH的可能性也更高(IRR = 1.40,95%置信区间=1.24 - 1.59)(<0.001)。出生于东南亚和大洋洲地区的人SAH风险显著增加,而出生于东南亚和东北亚的居民致命性SAH风险更高。居住在最不贫困地区的人住院风险最低(IRR = 0.83,95%置信区间=0.74 - 0.92),致命性SAH风险也最低(0.81,95%置信区间=0.66 - 1.00)(分别为<0.001和=0.003)。如果我们人群中的SAH风险与社会经济最优越人群的风险相当,那么每100例SAH入院病例中,男性和女性分别可能避免20例和15例。
我们的研究报告了SAH死亡率风险的降低,这与医疗服务提供方面可识别的变化以及诸如栓塞等不断发展的治疗方法相对应。解决SAH风险和死亡率方面的不平等问题可能需要针对普遍且可改变的风险因素,以改善人群结局。